A new vaccine targeting the fastest spreading mosquito-borne virus and one of the top ten threats to global health recently gained another authorization.
Takeda UK Ltd. announced on February 6, 2023, that the Medicines and Healthcare products Regulatory Agency (MHRA) had granted marketing authorization for Qdenga® for active immunization against dengue infection in individuals from four years of age.
Read More
